Novolog
Product Images NDC 50090-1665

Product Visual Gallery

This gallery contains 67 technical images submitted to the FDA as part of the official labeling for Novolog (NDC 50090-1665). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig. 1 (Structural Formula of Insulin Aspart)

Chemical structure diagram of the A-chain and B-chain amino acid sequences of insulin, showing disulfide bonds linking cysteine residues. Each amino acid is depicted with its three-letter abbreviation along the peptide chains, illustrating the molecular composition of insulin.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing serum glucose concentration (mg/dL) on the vertical axis and time (hours) on the horizontal axis. Two curves are displayed: one dashed and one solid, representing different serum glucose response profiles over a 6-hour period.*

FDA Label Image

Fig. 3 (Pharmacodynamics Graph)

A line graph showing mean blood glucose levels (mg/dL) over time (minutes) with data points before and after a reference time (R). The graph includes error bars and notes slashes on the time axis indicating jumps in time intervals.*

FDA Label Image

Figure 4 (Image 04)

A line graph depicting free serum insulin levels (mU/L) over time in hours (h). The x-axis represents time from 0 to 6 hours, and the y-axis shows free serum insulin concentration ranging up to about 80 mU/L. Two lines are shown: a solid line with a sharp peak near 0.5 hours followed by a decline, and a dashed line with a lower, more gradual rise and fall over the 6-hour period.*

FDA Label Image

Vial Figure (Image 05)

An instructional diagram showing a vial with labeled components: a tamper-resistant cap on top and a rubber stopper under the cap.*

FDA Label Image

Hand And Vial Figure (Image 06)

An illustration showing a hand holding a small vial, suggesting how to hold or handle a medication vial, potentially related to the NOVOLOG 100 [iU]/mL product by A-S Medication Solutions.*

FDA Label Image

Figure A And Figure B (Image 07)

An instructional illustration showing a hand holding and manipulating a small vial or container. Two panels labeled Figure A and Figure B demonstrate different steps or positions for preparing or handling the vial, possibly related to medication administration or preparation.*

FDA Label Image

Figure C (Image 08)

An instructional illustration showing a hand holding a syringe with a needle, poised above a vial, with a downward arrow indicating the needle should be inserted into the vial. An inset zooms in on the syringe barrel, clearly showing measurement markings.*

FDA Label Image

Figure D (Image 09)

An instructional diagram showing hands holding a syringe and a vial. The illustration depicts the process of drawing liquid medication from the vial into the syringe, emphasizing proper technique for preparing an injectable dose.*

FDA Label Image

Figure E (Image 10)

An instructional illustration showing a hand pulling a needle cap off a syringe containing NOVOLOG insulin. The image demonstrates proper needle preparation for injection.*

FDA Label Image

Figure F (Image 11)

An instructional diagram showing a hand holding a vial upside down and another hand holding a syringe beneath it. An arrow indicates the direction of drawing liquid from the vial into the syringe, labeled as Figure F.*

FDA Label Image

Figure G (Image 12)

An instructional illustration showing a person drawing liquid from a vial into a syringe. The image highlights the proper way to prepare an injection dose, with one hand holding the vial upside down and the other hand pulling the syringe plunger to fill it.*

FDA Label Image

Figure H (Image 13)

An instructional illustration showing hands preparing an injection syringe. The image depicts drawing liquid from a vial into the syringe, with an arrow indicating upward movement to fill the syringe. A close-up inset shows the syringe barrel with measurement markings.*

FDA Label Image

Figure I (Image 14)

An instructional illustration showing a hand drawing up medication from a vial into a syringe, indicated by an upward arrow pointing from the vial to the syringe needle. This likely demonstrates a step in preparing a dose of medication, relevant to NOVOLOG 100 IU/mL insulin.*

FDA Label Image

Fig. J (Image 15)

An illustration diagram showing front and back views of a human figure with shaded areas indicating common injection sites. The front view highlights the abdomen and upper thigh areas, while the back view highlights the upper buttocks. This is likely instructional for subcutaneous injection sites.*

FDA Label Image

Figure K (Image 16)

An instructional illustration labeled Figure K showing a person using both hands to remove the cap from a syringe or pen device needle. The right hand holds the needle cap with an arrow indicating the direction of pulling away to detach the cap.*

FDA Label Image

Figure L (Image 17)

An instructional illustration showing a hand holding an injection pen with the needle inserted into the skin of the forearm. The other hand is pressing the injection pen to administer the dose, indicated by an arrow pointing upward.*

FDA Label Image

Figure A Penfill Cartridge And Needle Components. (Image 18)

An instructional illustration showing components of NovoFine, NovoFine Plus, and NovoTwist needles, including outer needle cap, inner needle cap, needle, and paper tab. Also depicted is a PenFill cartridge compatible insulin delivery device with labels identifying the pen cap, cartridge holder, threaded end for needle attachment, colored band, rubber plunger, dose pointer, dose counter, and dose selector/dose button. The PenFill cartridge shown is a 3 mL example.*

FDA Label Image

Figure B: Check The Penfill Cartridge. (Image 19)

An instructional illustration showing a hand holding a pen-like device with a threaded end highlighted. The image focuses on the device's threaded end for connection purposes, without additional text or branding.*

FDA Label Image

Figure C: Insert The Cartridge. (Image 20)

An instructional illustration showing a hand holding a syringe and another hand holding a vial or cartridge. An arrow indicates the action of drawing fluid from the vial or cartridge into the syringe, demonstrating preparation steps for injection.*

FDA Label Image

Figure D: Pust The Needle Straight On. (Image 21)

Illustration comparing the insertion methods of NovoFine and NovoTwist needles in a NovoLog injection device, demonstrating the proper alignment and attachment techniques for each needle type.*

FDA Label Image

Figure E: Pull Off The Outer Needle Cap. (Image 22)

An instructional illustration showing hand positioning to twist off caps labeled NovoFine, NovoFine Plus, and NovoTwist. The graphic includes arrows indicating the twisting direction for removal.*

FDA Label Image

Figure F: Pull Off The Inner Needle Cap. (Image 23)

An instructional diagram comparing two injection devices labeled 'NovoFine NovoFine Plus' and 'NovoTwist.' Each panel shows a hand gripping the device with a blue arrow pointing to the right, illustrating attachment or alignment instructions for the needle or device component.*

FDA Label Image

Figure G: Insulin Squirts. (Image 24)

The image shows a medical vial labeled as NOVOLOG 100 IU/mL. The vial has a blue label and is topped with a gray cap attached to a flexible, curved tubing or tip, typically used for precise dispensing or injection. The labeler is A-S Medication Solutions.*

FDA Label Image

Figure H: Select Your Dose. (Image 25)

An instructional diagram illustrating components of a dose selector mechanism. It labels the dose counter, dose selector, dose pointer, and shows an example of the number 12 units selected. The diagram visually explains how to read and set the dose on the device.*

FDA Label Image

Figure I: Injection Sites (Image 26)

An instructional illustration showing recommended injection sites for a medication. The diagram depicts a human figure with labels pointing to the upper arms, abdomen, upper thighs, and buttocks as places to inject.*

FDA Label Image

Figure J: Count Slowly. (Image 27)

An instructional illustration showing a hand holding an insulin pen while counting slowly from 1 to 6. The image appears to demonstrate the technique for administering an insulin injection, focusing on how to hold the pen and count during the process.*

FDA Label Image

Figure J: Lead The Needle Tip Into The Outer Cap. (Image 28)

An instructional diagram showing the connection of a needle to a syringe. The image includes arrows indicating the direction to attach the needle to the syringe, illustrating assembly steps.*

FDA Label Image

Figure K: Unscrew The Needle. (Image 29)

An instructional illustration showing how to remove the cartridge holder from an insulin pen device by gripping and pulling it upwards. The cartridge holder is labeled on the image, and hands are depicted holding the device to demonstrate the removal process.*

FDA Label Image

Figure L: Put The Cap On The Device. (Image 30)

An instructional illustration shows a hand holding a pen injector, pressing the pen tip down while the other hand is positioned underneath, indicating injection technique or priming of the pen device associated with NOVOLOG insulin delivery.*

FDA Label Image

Figure A: Flextouch Pen And Needle Components. (Image 31)

Illustration depicting components of NovoFine, NovoFine Plus, and NovoTwist insulin pen needles, showing outer needle cap, inner needle cap, needle, and paper tab for each type. Below, a labeled diagram of a NovoLog FlexTouch insulin injection pen indicates parts including pen cap, insulin scale, insulin window, dose counter, dose selector, dose pointer, and dose button.*

FDA Label Image

Figure B (Image 32)

An instructional illustration showing a person holding a NovoLog insulin vial or pen and inserting or removing a needle cover. The image demonstrates proper handling or preparation technique for the NovoLog 100 IU/mL insulin product by A-S Medication Solutions.*

FDA Label Image

Figure C (Image 33)

An instructional illustration showing a hand holding an insulin pen with a protective orange needle cap attached, likely demonstrating preparation or handling of the device.*

FDA Label Image

Figure D: Pull Off Paper Tab. (Image 34)

An instructional illustration showing two types of pen needles, NovoFine/NovoFine Plus and NovoTwist, each held by a hand with an arrow indicating the direction to attach or remove the needle from an insulin pen. The diagram visually compares the two needle types by demonstrating their handling method.*

FDA Label Image

Figure E: Twist The Needle On. (Image 35)

Instructional illustration for NovoLog showing how to remove the pen cap from NovoFine/NovoFine Plus and NovoTwist pen needles by twisting and pulling off the cap, demonstrating proper preparation steps for injection.*

FDA Label Image

Figure F: Pull Off Outer Needle Cap. (Image 36)

An instructional illustration showing how to attach two parts: one labeled NovoFine or NovoFine Plus, and the other labeled NovoTwist. Both images depict a hand holding the parts with an arrow indicating the direction to connect or twist them together.*

FDA Label Image

Figure G: Pull Off The Inner Needle Cap. (Image 37)

An instructional illustration comparing NovoFine or NovoFine Plus pen needles with NovoTwist pen needles. It shows how to attach each needle type to a pen device, highlighting the different attachment methods with arrows indicating the connection process.*

FDA Label Image

Figure H (Image 38)

An instructional illustration showing a close-up of hands adjusting an insulin pen dial to select a dose. The pen's display window shows '2 units selected,' indicating dose selection on the device, likely for NOVOLOG insulin 100 IU/mL.*

FDA Label Image

Figure I (Image 39)

An instructional illustration showing a hand holding and shaking a small pen device, likely an insulin pen. The pen is depicted vertically with motion lines indicating shaking or mixing before use. No text or branding is visible on the device itself.*

FDA Label Image

Figure J (Image 40)

An instructional diagram showing a hand holding a NOVOLOG insulin pen with the cap being removed by pulling it straight off. The pen is marked with dosage indicators, and a small inset highlights the pen tip as the cap is lifted upward.*

FDA Label Image

Figure K (Image 41)

An instructional illustration showing a user adjusting the dose selector on an insulin pen, with examples displaying 5 units and 24 units selected. The diagram depicts rotating a numbered dial to choose the desired insulin unit dosage.*

FDA Label Image

Figure L (Image 42)

An illustration showing a portion of an orange insulin pen cartridge with a visible dose window and a knob on top. The dose scale reads from 15 to 75 units, highlighting approximate remaining insulin units. Text next to the pen indicates an example of approximately 200 units left. This image relates to the NOVOLOG 100 [iU]/mL insulin product from A-S Medication Solutions.*

FDA Label Image

Figure M (Image 43)

An anatomical illustration showing the front and back views of a female body with shaded areas indicating recommended injection sites on the abdomen and upper thighs in the front view, and the upper buttocks in the back view. This diagram is commonly used to guide subcutaneous injection placement for medications like NOVOLOG 100 IU/mL.*

FDA Label Image

Figure N (Image 44)

Illustration showing a hand holding an insulin pen with a downward arrow beneath it, likely indicating a step in the preparation or use of the pen device for medication administration.*

FDA Label Image

Figure O (Image 45)

An instructional illustration showing a hand holding a syringe and pressing it downward against a forearm, demonstrating the injection technique. The image includes an inset with an icon of a syringe and a finger pressing a button.*

FDA Label Image

Figure P (Image 46)

An instructional illustration showing a hand holding an insulin pen with the cap removed. The hand is pressing down on the pen to administer a dose, accompanied by a speech bubble instructing to count slowly from 1 to 6, indicating a timing cue during injection.*

FDA Label Image

Figure Q (Image 47)

An instructional illustration showing a syringe with an upward arrow above the needle area, indicating the removal of an air bubble or expelling air from the syringe prior to injection. No specific product branding visible in the image itself.*

FDA Label Image

Figure R: Remove The Needle. (Image 48)

Instructional illustration showing two types of pen needles labeled as NovoFine/ NovoFine Plus and NovoTwist. It demonstrates the correct method of attaching each needle to a pen device, with arrows indicating the twisting direction for NovoFine/ NovoFine Plus and the pulling direction for NovoTwist.*

FDA Label Image

Figure S (Image 49)

Illustration showing the proper attachment of a needle to an insulin pen device. The image depicts a close-up of a pen needle being aligned and pushed onto the pen, with arrows indicating the direction for attaching.*

FDA Label Image

Figure T (Image 50)

An instructional illustration showing hands peeling off an orange safety cap from a pen-type medication device labeled NOVOLOG 100 units/mL by A-S Medication Solutions. The image demonstrates removing the protective cap prior to use.*

FDA Label Image

Flextouch Qr Code Placeholder (Image 51)

FDA Label Image

Flextouch Cover (Image 52)

The image shows a segment of a packaging label for NovoLog FlexTouch, an insulin delivery pen. The label includes the distinctive orange bar at the top, the NovoLog FlexTouch name in blue text, and the instruction to "Read before first use." The label also features the Novo Nordisk logo at the bottom right corner.*

FDA Label Image

Flexpen And Needle Components. (Image 53)

Illustration showing components of the NovoLog FlexPen and needle types: NovoFine, NovoFine Plus, and NovoTwist. The FlexPen includes a pen cap, rubber stopper, cartridge with scale, dose pointer selector, and push button. Each needle type features a big outer needle cap, inner needle cap, needle, and protective tab.*

FDA Label Image

A (Preparing the NovoLog FlexPen)

An instructional illustration showing a hand holding a pen-like device with a cap being removed by pulling it upwards. This is typically indicative of the first step in preparing a pen injector for use.*

FDA Label Image

Diagram B: Attaching The Needle. (Image 55)

An instructional illustration showing how to attach or lock the NovoFine or NovoFine Plus and NovoTwist needles. It depicts a person holding the needle and pen device, with arrows indicating the locking motion or attachment direction for proper needle connection.*

FDA Label Image

Diagram C: Pull Off The Outer Needle Cap. (Image 56)

An instructional diagram illustrating how to use NovoFine and NovoFine Plus needles, showing the proper method to attach a NovoTwist needle with step-by-step hand positioning and arrow indicators for twisting.*

FDA Label Image

Diagram D: Pull Off Inner Needle Cap. (Image 57)

An instructional illustration showing the use of a NovoFine or NovoFine Plus needle and a NovoTwist needle, demonstrating how to attach or use each type. Both images depict close-up views of hands handling the needles, indicating different needle attachment methods.*

FDA Label Image

E (Giving the airshot before each injection- Turn the dose selector to select 2 units)

Illustration showing a close-up of a hand adjusting a dosing dial on an injector pen, with a focus on selecting a dose of 2 units, indicated clearly on the device.*

FDA Label Image

F (Giving the airshot before each injection)

An instructional illustration showing a hand holding a pen-like device with a needle end, with motion lines indicating shaking or tapping. A letter "F" in a blue square is in the top left corner of the image. This likely relates to preparation or use instructions for the product NOVOLOG 100 iU/mL by A-S Medication Solutions.*

FDA Label Image

G (Giving the airshot before each injection)

An instructional illustration showing a hand holding a blue device with a needle attached at the bottom. An upward arrow indicates pulling or lifting the top part of the device. The inset shows a close-up of the needle and device tip. The image likely depicts a step in preparing an injection device for use.*

FDA Label Image

H (Selecting the dose)

An instructional illustration demonstrating the dosing selection mechanism on an insulin pen for NOVOLOG insulin 100 IU/mL. The image shows a hand dialing doses, highlighting examples of 5 units and 24 units selected on the pen's dose window.*

FDA Label Image

I (Giving the injection)

An instructional illustration showing a hand holding a medication vial with the finger pressing down on the vial top. A second vial is positioned horizontally with a focus zoom on a measurement window displaying a dose indicator. The image demonstrates preparing or measuring a dose, likely relevant to the use of NOVOLOG 100 [iU]/mL insulin.*

FDA Label Image

J (Giving the injection)

An illustration showing the tip of a pen injector needle about to be inserted into the skin, demonstrating the injection step for the NOVOLOG 100 [iU]/mL insulin product by A-S Medication Solutions.*

FDA Label Image

K (After the injection)

An instructional diagram showing the proper technique for using a dial-type injector pen. It depicts a hand holding the pen with an arrow indicating the direction to turn or adjust the dial, likely to set the dosage.*

FDA Label Image

Label Image (Lbl500901664)

NOVOLOG 100 [iU]/mL Insulin Aspart Injection label from A-S Medication Solutions. The label states the product contains 100 units of Insulin Aspart per milliliter, is to be stored refrigerated at 36 to 46 degrees Fahrenheit, and includes a 10 mL multiple-dose vial. The NDC number 50090-1664-0 and Product No. 6584-0 are also shown.*

FDA Label Image

Lbl500901665

Packaging label for NOVOLOG insulin injection, strength 100 units per mL, in 3 mL prefilled pens. Label shows product number 6586-0 and emphasizes storage instructions to keep in a cold place, avoid freezing, and protect from light. Distributed by A-S Medication Solutions, Libertyville, Illinois.*

FDA Label Image

Lbl500901678

Label for NOVOLOG Insulin Aspart Injection, 100 Units per mL, supplied by A-S Medication Solutions. The label includes a lot number, product number 6587-0, and states the package contains five 3 mL prefilled insulin syringes with 100 units of insulin aspart each. Storage instructions specify keeping the product refrigerated at 36 to 46 degrees Fahrenheit and protecting it from light.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.